|
|
Article: Symphogen Appoints Jorgen Petersen as Chief Development Officer.
- Article from:
- Biotech Week
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Symphogen A/S announced that Jorgen Petersen, M.D., DMSc, has joined the company's executive management team as Chief Development Officer. Dr. Petersen comes to Symphogen from Genmab A/S (see also Symphogen).
"As Symphogen is progressing its novel pipeline towards later stage clinical programs we have significantly strengthened our executive leadership team with the recruitment of Jorgen Petersen," said Kirsten Drejer, Ph.D., CEO of Symphogen. "As co-founder of Genmab and an immunologist and rheumatologist, Jorgen brings to Symphogen an exceptional scientific and medical background. While at Genmab, Jorgen developed a deep expertise in executing successful ...